Tokyo startup confirms efficacy of iPS cell-derived heart muscle transplants ...Middle East

According to Friday's announcement, the transplant was performed on 10 patients, and no major safety issues were confirmed.

Hence then, the article about tokyo startup confirms efficacy of ips cell derived heart muscle transplants was published today ( Saturday 13/12/2025 - 11:24 AM ) and is available on japan times ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Tokyo startup confirms efficacy of iPS cell-derived heart muscle transplants )

Also on site :

• Anycubic Opens Deposits for Kobra X, Following Formnext Debut of Its Next-Generation Entry-Level Multicolor FDM Printer
• AR Accessibility Research Wins AIS Impact Award 2025 with Support from LLVision Smart Glasses
• Numbrix 9 - December 26